Spain· ES:114970004
Rixubis 2000UI/vial polvo y disolvente para solucion inyectable
A nonacog gamma product containing nonacog gamma, registered in Spain by Baxalta Innovations Gmbh. The same ATC class is registered in 3 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Nonacog gamma is registered in 3 of 19 countries.
Countries holding a registration under ATC B02BD29 (nonacog gamma), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 2 of them publish a price we can compare per daily dose
Nonacog gamma · ATC B02BD29
3 / 19 countries
- Franceprice
- Spainprice
- United Kingdom
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- nonacog gamma
- Manufacturer
- Baxalta Innovations Gmbh
- Country
- Spain (ES)
- ATC code
- B02BD29
- ATC class
- Nonacog gamma
- Defined daily dose
- 800 E, P
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nonacog gamma in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBeneFIX 2000 IUPfizer Europe MA
- SwedenBeneFIX 2000 IE Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- CzechiaBENEFIXPfizer Europe MA EEIG, Bruxelles
- FinlandBenefixPfizer Europe MA EEIG
- IrelandBeneFIX 1000 IU powder and solvent for solution for injectionPfizer Europe MA EEIG
- IcelandBeneFIXPfizer Europe MA EEIG*
- PolandBeneFixPfizer Europe MA EEIG
- FranceBENEFIX 1000 UI, poudre et solvant pour solution injectablePFIZER EUROPE MA EEIG (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Benefix, Rixubis
- Liechtenstein · Benefix, Rixubis
- Norway · Benefix, Rixubis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb1ace38-7a58-4b9c-b657-cc299c82b292 GET /v1/drugs/bb1ace38-7a58-4b9c-b657-cc299c82b292?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1453155275000}",
"nregistro": "114970004",
"substance": "nonacog gamma"
}See everything about nonacog gamma.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.